Gepirone

Chemical formula: C₁₉H₂₉N₅O₂  Molecular mass: 359.474 g/mol  PubChem compound: 55191

Therapeutic indications

Gepirone is indicated for:

Major depressive disorder

Population group: only adults (18 years old or older)

Major depressive disorder

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Gepirone is contraindicated in the following cases:

Severe hepatic impairment

Hepatic failure stage IV

Strong CYP3A4 inhibitors

Strong CYP3A4 inhibitors

Monoamine oxidase inhibitors

Monoamine oxidase inhibitors (MAOIs)

Prolonged QTc interval >450 msec at baseline

Prolonged QT interval

Congenital long QT syndrome

Congenital long QT syndrome

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Structured Product Labeling (SPL/PLR) 2023: EXXUA Delayed release tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈